Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 8651708)

Published in Arch Biochem Biophys on June 01, 1996

Authors

D C Zeldin1, C R Moomaw, N Jesse, K B Tomer, J Beetham, B D Hammock, S Wu

Author Affiliations

1: Laboratories of Pulmonary Pathology and Molecular Biophysics, National Institute of Environmental Sciences, Research Triangle Park, North Carolina 27709, USA.

Articles citing this

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A (2006) 2.07

Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev (2012) 1.82

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J (2010) 1.48

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci U S A (2009) 1.40

Epoxyeicosatrienoic acid analogs and vascular function. Curr Med Chem (2010) 1.11

Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. J Mol Cell Cardiol (2009) 1.05

Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450. J Lipid Res (2009) 0.98

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics (2008) 0.95

Human liver expression of CYP2C8: gender, age, and genotype effects. Drug Metab Dispos (2010) 0.95

Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. J Med Chem (2014) 0.89

Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide. Chem Res Toxicol (2013) 0.88

Analysis of epoxyeicosatrienoic acids by chiral liquid chromatography/electron capture atmospheric pressure chemical ionization mass spectrometry using [13C]-analog internal standards. Rapid Commun Mass Spectrom (2010) 0.84

Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol (2013) 0.84

Molecular cloning and enzymatic characterization of sheep CYP2J. Xenobiotica (2010) 0.84

Impaired transactivation of the human CYP2J2 arachidonic acid epoxygenase gene in HepG2 cells subjected to nitrative stress. Br J Pharmacol (2010) 0.82

Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7. J Biol Chem (2014) 0.77

Genetic polymorphisms of CYP2C8 in the Czech Republic. Genet Test Mol Biomarkers (2012) 0.77

Bioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposure. J Metabolomics (2015) 0.76

Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8. Front Pharmacol (2015) 0.75

Modulation of arachidonic Acid metabolism in the rat kidney by sulforaphane: implications for regulation of blood pressure. ISRN Pharmacol (2014) 0.75

In-silico and In-vitro based studies of Streptomyces peucetius CYP107N3 for oleic acid epoxidation. BMB Rep (2012) 0.75

Articles by these authors

ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell (1993) 5.75

Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol (2001) 5.57

A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. Physiol Genomics (2001) 4.50

Stress: a factor to be considered in heterotrophic microorganism enumeration from aquatic environments. Appl Microbiol (1974) 4.03

Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res (2000) 3.70

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13

Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med (1997) 3.05

Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A (2000) 2.96

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem (1996) 2.95

Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J (1993) 2.80

Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc Natl Acad Sci U S A (1999) 2.79

Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature (1991) 2.57

Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med (1990) 2.56

Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry (2000) 2.46

Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res (2005) 2.38

Intracellular signalling: PDK1--a kinase at the hub of things. Curr Biol (1999) 2.31

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest (1999) 2.21

An unusual human IgM antibody with a protruding HCDR3 and high avidity for its peptide ligands. Mol Immunol (2000) 2.04

Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem (1993) 2.03

Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science (2000) 2.01

PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family. J Biol Chem (1994) 2.00

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5. J Virol (2001) 1.99

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology (1998) 1.98

cDNA cloning and expression of a soluble epoxide hydrolase from human liver. Arch Biochem Biophys (1993) 1.93

Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem (1997) 1.92

Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol (1998) 1.91

Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol (1994) 1.88

Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem (2001) 1.87

Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol (1994) 1.85

A rapid assay for insect juvenile hormone esterase activity. Anal Biochem (1977) 1.82

Improved radiolabeled substrates for soluble epoxide hydrolase. Anal Biochem (1995) 1.79

Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. Proc Natl Acad Sci U S A (1999) 1.76

Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels. Anal Biochem (1988) 1.67

Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol (1998) 1.67

Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J (2001) 1.67

The role of oxidative stress in indium phosphide-induced lung carcinogenesis in rats. Toxicol Sci (2001) 1.65

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci (1998) 1.61

Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61

Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect Immun (1997) 1.58

The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch Biochem Biophys (1983) 1.55

Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. Implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis. FEBS Lett (1994) 1.55

Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature (1995) 1.54

Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology (2007) 1.53

Stigmatization and shame: consequences of caring for HIV/AIDS patients in China. AIDS Care (2007) 1.53

Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells. Am J Transplant (2013) 1.52

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

The nature of giant cell tumor of bone. J Cancer Res Clin Oncol (2001) 1.47

Heat shock response of spirochetes. Infect Immun (1991) 1.47

A stereoselective cobalt-containing nitrile hydratase. Biochemistry (1997) 1.46

Massive reduction in methicillin resistance by transposon inactivation of the normal PBP2 in a methicillin-resistant strain of Staphylococcus aureus. Microb Drug Resist (1997) 1.45

Larva lights: a decade of photoaffinity labeling with juvenile hormone analogues. Insect Biochem Mol Biol (1994) 1.45

Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol (1998) 1.44

Coronary artery fistulae. Am J Med Sci (2006) 1.44

Existence of two gamma subunits of the G proteins in brain. J Biol Chem (1989) 1.43

Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol (1999) 1.42

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42

Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy. Prostate Cancer Prostatic Dis (2012) 1.42

Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation. J Biol Chem (2000) 1.42

Contribution of endogenously expressed Trp1 to a Ca2+-selective, store-operated Ca2+ entry pathway. FASEB J (2001) 1.41

The X-ray crystal structure of the Trichoderma reesei family 12 endoglucanase 3, Cel12A, at 1.9 A resolution. J Mol Biol (2001) 1.41

Unconventional gap state of trapped exciton in lead sulfide quantum dots. Nanotechnology (2010) 1.41

High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene (1999) 1.40

Primary structure and topological analysis of a skeletal muscle-specific junctional sarcoplasmic reticulum glycoprotein (triadin). J Biol Chem (1993) 1.39

p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase. Oncogene (2000) 1.39

Attenuation of esophageal shortening during peristalsis with hiatus hernia. Gastroenterology (1995) 1.39

Allergy and risk of glioma: a meta-analysis. Eur J Neurol (2010) 1.38

Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal. J Cell Biol (1999) 1.38

Admixture and population stratification in African Caribbean populations. Ann Hum Genet (2006) 1.37

Expression and characterization of recombinant human acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides. Biochemistry (1991) 1.36

Optimized expression of green fluorescent protein in Toxoplasma gondii using thermostable green fluorescent protein mutants. Mol Biochem Parasitol (2001) 1.35

Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J Biol Chem (1994) 1.34

Molecular cloning and expression of murine liver soluble epoxide hydrolase. J Biol Chem (1993) 1.34

Sequence analysis of the 47-kilodalton major integral membrane immunogen of Treponema pallidum. Infect Immun (1989) 1.33

AFM imaging of bacteria in liquid media immobilized on gelatin coated mica surfaces. Ultramicroscopy (2003) 1.31

Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. Arch Biochem Biophys (1998) 1.30

Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30

Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch Biochem Biophys (1995) 1.29

Direct measurement of human-cone-photoreceptor alignment. J Opt Soc Am A Opt Image Sci Vis (1995) 1.28

Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase. Anal Biochem (1983) 1.27

Nin1p, a regulatory subunit of the 26S proteasome, is necessary for activation of Cdc28p kinase of Saccharomyces cerevisiae. EMBO J (1995) 1.27

Development of a highly sensitive enzyme-linked immunosorbent assay based on polyclonal antibodies for the detection of polychlorinated dibenzo-p-dioxins. Anal Chem (1998) 1.27

Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome. Am J Respir Cell Mol Biol (2001) 1.27

Evolutionary conservation of apoptosis mechanisms: lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9. Proc Natl Acad Sci U S A (2000) 1.26

Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J Bacteriol (1999) 1.26

Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiol Aging (2009) 1.26

Detection and analysis of epoxides with 4-(p-Nitrobenzyl)-pyridine. Bull Environ Contam Toxicol (1974) 1.25

Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J Biol Chem (1993) 1.25

Molecular cloning of the mature NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression. J Biol Chem (1995) 1.24

Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. Am J Med Genet (1996) 1.24

Phage anti-immune complex assay: general strategy for noncompetitive immunodetection of small molecules. Anal Chem (2007) 1.24

Molecular cloning of a histidine-rich Ca2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements. J Biol Chem (1989) 1.24

Spectrophotometric substrates for cytosolic epoxide hydrolase. Anal Biochem (1994) 1.23

ESR spin-trapping of a protein-derived tyrosyl radical from the reaction of cytochrome c with hydrogen peroxide. J Biol Chem (1996) 1.22

Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase. J Biol Chem (2000) 1.22

First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21

A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol Cell Biol (1995) 1.21

Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell (1996) 1.21